artificial intelligence

News

Genentech, NVIDIA partner on ‘lab-in-a-loop’ AI platform

NVIDIA’s push into the life sciences sector has been rewarded by a wide-ranging deal with Roche’s Genentech subsidiary aimed at accelerating the use of generative artifici

News

Bayer pledges up to $1.5bn for Recursion oncology alliance

Bayer has restructured and expanded its ongoing partnership with Recursion Pharmaceuticals on artificial intelligence-powered drug discovery, switching to a focus on cance

News

Owkin signs up another pharma partner for its AI platform

France’s Servier has become the latest pharma group to tap into an artificial intelligence platform for drug discovery, development, and diagnostics developed by Franco-US

News

Sanofi partners BioMap on AI hunt for biologic therapies

Sanofi has added another dimension to the use of artificial intelligence (AI) to seek out new drugs, partnering with BioMap on a project to find biologic therapies in a de

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Harnessing omnichannel, AI, and beyond: Reimagining scientif...

Artificial intelligence (AI) and omnichannel have come to seem mere buzzwords these days in the life sciences – everyone is talking about them, everyone wants to use them.

News

Exscientia trims pipeline to focus on top cancer prospects

UK biotech Exscientia has tapped the brakes on the rapid expansion of its R&D pipeline, narrowing its in-house activities to oncology programmes that it says offer the

Genentech, NVIDIA partner on ‘lab-in-a-loop’ AI platform

Bayer pledges up to $1.5bn for Recursion oncology alliance

Owkin signs up another pharma partner for its AI platform

Sanofi partners BioMap on AI hunt for biologic therapies

Harnessing omnichannel, AI, and beyond: Reimagining scientif...

Exscientia trims pipeline to focus on top cancer prospects

Europe is facing a surge in STIs, says ECDC

Discover a new era of healthcare panel engagement: Grounded ...

artificial intelligence

Editor's Picks